-
Je něco špatně v tomto záznamu ?
Tick salivary cystatin Iristatin limits the virus replication in skin of tick-borne encephalitis virus-infected mice
H. Langhansová, Z. Beránková, R. Khanna, J. Kotál, M. Kotsyfakis, M. Palus, J. Lieskovská
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
19-15678S
Grantová Agentura České Republiky
19-15678S
Grantová Agentura České Republiky
19-15678S
Grantová Agentura České Republiky
19-15678S
Grantová Agentura České Republiky
LX22NPO5103
European Union-Next Generation EU
- MeSH
- antivirové látky farmakologie MeSH
- cystatiny farmakologie metabolismus genetika MeSH
- dendritické buňky virologie účinky léků MeSH
- klíště * virologie účinky léků MeSH
- klíšťová encefalitida * virologie MeSH
- kůže * virologie MeSH
- makrofágy virologie MeSH
- mozek virologie metabolismus MeSH
- myši MeSH
- replikace viru * účinky léků MeSH
- RNA virová genetika MeSH
- slinné cystatiny metabolismus MeSH
- viry klíšťové encefalitidy * účinky léků fyziologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Tick-borne encephalitis virus (TBEV) is flavivirus transmitted to the host via tick saliva which contains various molecules with biological impacts. One of such molecules is Iristatin, a cysteine protease inhibitor from Ixodes ricinus that has been shown to have immunomodulatory properties. To characterize Iristatin in the relation to TBEV, we investigate whether this tick inhibitor has any capacity to influence TBEV infection. Mice were intradermally infected by TBEV with or without Iristatin and the viral multiplication was determined in skin and brain tissues by RT-PCR two and 5 days after infection. The viral RNA was detected in both intervals in skin and increased by time. The application of Iristatin caused a reduction in viral RNA in skin but not in the brain of infected mice 5 days post-infection. Moreover, anti-viral effect of Iristatin on skin was accompanied by a significant decline of interferon-stimulated gene 15 gene expression. The effect of Iristatin on TBEV replication was tested also in vitro in primary macrophages and dendritic cells; however, no changes were observed suggesting no direct interference of Iristatin with virus replication. Still, the Iristatin caused a suppression of Erk1/2 phosphorylation in TBEV-infected dendritic cells and had the anti-apoptotic effect. This is the first report showing that a tick cystatin decreases the viral RNA in the host skin, likely indirectly through creating skin environment that is less supportive for TBEV replication. Assuming, that viral RNA reflects the amount of infectious virus, decline of TBEV in host skin could influence the tick biology or virus transmission during cofeeding.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010238
- 003
- CZ-PrNML
- 005
- 20250429134811.0
- 007
- ta
- 008
- 250415s2025 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00436-024-08441-5 $2 doi
- 035 __
- $a (PubMed)39821815
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Langhansová, Helena $u Department of Medical Biology, Faculty of Science, University of South Bohemia, Branišovská 1760, CZ-37005, České Budějovice, Czech Republic
- 245 10
- $a Tick salivary cystatin Iristatin limits the virus replication in skin of tick-borne encephalitis virus-infected mice / $c H. Langhansová, Z. Beránková, R. Khanna, J. Kotál, M. Kotsyfakis, M. Palus, J. Lieskovská
- 520 9_
- $a Tick-borne encephalitis virus (TBEV) is flavivirus transmitted to the host via tick saliva which contains various molecules with biological impacts. One of such molecules is Iristatin, a cysteine protease inhibitor from Ixodes ricinus that has been shown to have immunomodulatory properties. To characterize Iristatin in the relation to TBEV, we investigate whether this tick inhibitor has any capacity to influence TBEV infection. Mice were intradermally infected by TBEV with or without Iristatin and the viral multiplication was determined in skin and brain tissues by RT-PCR two and 5 days after infection. The viral RNA was detected in both intervals in skin and increased by time. The application of Iristatin caused a reduction in viral RNA in skin but not in the brain of infected mice 5 days post-infection. Moreover, anti-viral effect of Iristatin on skin was accompanied by a significant decline of interferon-stimulated gene 15 gene expression. The effect of Iristatin on TBEV replication was tested also in vitro in primary macrophages and dendritic cells; however, no changes were observed suggesting no direct interference of Iristatin with virus replication. Still, the Iristatin caused a suppression of Erk1/2 phosphorylation in TBEV-infected dendritic cells and had the anti-apoptotic effect. This is the first report showing that a tick cystatin decreases the viral RNA in the host skin, likely indirectly through creating skin environment that is less supportive for TBEV replication. Assuming, that viral RNA reflects the amount of infectious virus, decline of TBEV in host skin could influence the tick biology or virus transmission during cofeeding.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a viry klíšťové encefalitidy $x účinky léků $x fyziologie $7 D004669
- 650 _2
- $a myši $7 D051379
- 650 12
- $a replikace viru $x účinky léků $7 D014779
- 650 12
- $a klíště $x virologie $x účinky léků $7 D018884
- 650 12
- $a kůže $x virologie $7 D012867
- 650 12
- $a klíšťová encefalitida $x virologie $7 D004675
- 650 _2
- $a makrofágy $x virologie $7 D008264
- 650 _2
- $a mozek $x virologie $x metabolismus $7 D001921
- 650 _2
- $a RNA virová $x genetika $7 D012367
- 650 _2
- $a slinné cystatiny $x metabolismus $7 D055333
- 650 _2
- $a antivirové látky $x farmakologie $7 D000998
- 650 _2
- $a dendritické buňky $x virologie $x účinky léků $7 D003713
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a cystatiny $x farmakologie $x metabolismus $x genetika $7 D015891
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Beránková, Zuzana $u Department of Medical Biology, Faculty of Science, University of South Bohemia, Branišovská 1760, CZ-37005, České Budějovice, Czech Republic
- 700 1_
- $a Khanna, Ritesh $u Department of Medical Biology, Faculty of Science, University of South Bohemia, Branišovská 1760, CZ-37005, České Budějovice, Czech Republic
- 700 1_
- $a Kotál, Jan $u Department of Medical Biology, Faculty of Science, University of South Bohemia, Branišovská 1760, CZ-37005, České Budějovice, Czech Republic
- 700 1_
- $a Kotsyfakis, Michail $u Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, N. Plastira 100, 70013, Heraklion, Crete, Greece
- 700 1_
- $a Palus, Martin $u Institute of Parasitology, Biology Centre of Czech Academy of Sciences, Branišovská 1160/31, CZ-37005, České Budějovice, Czech Republic $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100, Brno, Czech Republic
- 700 1_
- $a Lieskovská, Jaroslava $u Department of Medical Biology, Faculty of Science, University of South Bohemia, Branišovská 1760, CZ-37005, České Budějovice, Czech Republic. jlieskovska@prf.jcu.cz $u Institute of Parasitology, Biology Centre of Czech Academy of Sciences, Branišovská 1160/31, CZ-37005, České Budějovice, Czech Republic. jlieskovska@prf.jcu.cz
- 773 0_
- $w MED00003691 $t Parasitology research $x 1432-1955 $g Roč. 124, č. 1 (2025), s. 8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39821815 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134807 $b ABA008
- 999 __
- $a ok $b bmc $g 2311543 $s 1247319
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 124 $c 1 $d 8 $e 20250117 $i 1432-1955 $m Parasitology research $n Parasitol Res $x MED00003691
- GRA __
- $a 19-15678S $p Grantová Agentura České Republiky
- GRA __
- $a 19-15678S $p Grantová Agentura České Republiky
- GRA __
- $a 19-15678S $p Grantová Agentura České Republiky
- GRA __
- $a 19-15678S $p Grantová Agentura České Republiky
- GRA __
- $a LX22NPO5103 $p European Union-Next Generation EU
- LZP __
- $a Pubmed-20250415